Overcoming Barriers to Access

Our objective is to lower the cost of medicines, vaccines and tests through competition, to ensure patents are not a barrier to access and to push back against harmful trade deals or entrenched industry interests.

20. October 2017.

RCEP should not restrict global access to medicines and vaccines

As 16 countries negotiate the Regional Comprehensive Economic Partnership (RCEP) agreement in Incheon, Korea, MSF appeals to Korea and Japan to withdraw damaging proposals for access to medicines and vaccines. Read more

Photo by Sandra Smiley/MSF

Access Barriers: The Issues

© Juan Carlos Tomasi

Learn about the major barriers to access to drugs, tests and vaccines that MSF is trying to break down.

» Read more

Featured multimedia

Kala Azar: Still Waiting
Some three decades ago, a mystery disease spread throughout Sudan and what is now South Sudan, decimating communities, sewing fear, and killing scores...

Tags: Sudan, kala azar, visceral leishmaniasis, neglected diseases, R&D

↑ To top